Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
12.85
-0.80 (-5.86%)
Nov 20, 2026, 12:01 PM EST - Market open
Biohaven Stock Forecast
Stock Price Forecast
According to 17 analysts polled by S&P Global, Biohaven stock has a consensus rating of "Buy" and an average price target of $25.13. The average 1-year stock price forecast is 95.56% higher than the current stock price, while the lowest is $9.00 (-29.96%) and the highest is $48 (+273.54%).
Price Target: $25.13 (+95.56%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Biohaven stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 9 | 9 |
| Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Hold | 4 | 3 | 3 | 4 | 4 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 17 | 17 | 17 | 17 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $17 | Buy | Maintains | $17 | +32.30% | Nov 20, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates $14 → $35 | Buy | Reiterates | $14 → $35 | +172.37% | Nov 19, 2026 |
| UBS | UBS | Hold Maintains $11 → $15 | Hold | Maintains | $11 → $15 | +16.73% | Nov 3, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $19 → $21 | Buy | Reiterates | $19 → $21 | +63.42% | Nov 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Reiterates $10 | Hold | Reiterates | $10 | -22.18% | Nov 2, 2026 |
Financial Forecast
Revenue This Year
175.33M
Revenue Next Year
108.65M
from 175.33M
Decreased by -38.03%
EPS This Year
-1.39
from -5.55
EPS Next Year
-1.53
from -1.39
EPS and Forward PE are based on non-GAAP adjusted numbers.